Bone morphogenetic protein delivery systems

Spine

Volumn 27, Issue 16 SUPPL., 2002, Pages

  Seeherman, Howard ^a   Wozney, John ^a   Li, Rebecca ^a  

^a PFIZER INC   (United States)

Author keywords

Bone morphogenetic protein; Delivery systems; Osteoconduction; Osteoinduction

Indexed keywords

2 HYDROXYACID; ALGINIC ACID; BONE MORPHOGENETIC PROTEIN; CALCIUM PHOSPHATE; CALCIUM SULFATE; CHITOSAN; COLLAGEN; COLLAGEN TYPE 1; DRUG CARRIER; FIBRIN; GELATIN; GELFOAM; GLASS; HYALURONIC ACID; HYALURONIC ACID DERIVATIVE; HYDROXYAPATITE; INORGANIC COMPOUND; METAL DERIVATIVE; NEOOSTEO; OSTEOGENIC PROTEIN 1; POLOXAMER; POLY(2 HYDROXYACID); POLYANHYDRIDE; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIDE; POLYMER; POLYPROPYLENE; POLYSACCHARIDE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG; UNINDEXED DRUG; RECOMBINANT PROTEIN;

BONE DEVELOPMENT; BONE REMODELING; CERAMIC PROSTHESIS; COMPOSITE MATERIAL; DOSE RESPONSE; DRUG DELIVERY SYSTEM; HUMAN; MEDICAL LITERATURE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; REVIEW; SPINE FUSION; ANIMAL; BLOOD; BONE REGENERATION; DRUG EFFECT; GENETICS; METHODOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; OSSEOINTEGRATION; RECOMBINANT PROTEINS; SPINAL FUSION;

EID: 0037102139     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-200208151-00005     Document Type: Review

References (87)

1. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: Antagonism by noggin
2. The bone morphogenetic proteins antagonist noggin inhibits membranous ossification
3. Growth factor regulation of fracture repair
4. Synthetic biodegradable polymers for orthopaedic applications
5. The safety of OP-1 for lumbar fusion with decompression: A canine study: Comment
6. Biomechanical and histological aspects of fracture healing stimulated with osteogenic protein-1
7. Bioactive factors for bone tissue engineering
8. Evaluation of carriers of bone morphogenetic protein for spinal fusion
9. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate
10. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration
11. Osteoprogenitor cells within skeletal muscle
12. A single injection of rhBMP-2 enhances fracture healing in a rabbit ulnar osteotomy model
13. rhBMP-2 accelerates healing in a rabbit ulnar osteotomy model
14. A rationale for delivery of osteoinductive proteins
15. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects
16. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton
17. Bone morphogenetic protein excipients: Comparative observations on poloxamer
18. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model
19. Effect of recombinant osteogenic protein-1 on healing of segmental defects in nonhuman primates
20. Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine: A comparative endoscopic study using the Bagby and Kuslich interbody fusion device
21. Accelerated fracture healing by percutaneous injection of rhBMP-2 and Alpha-BSM
22. Enhancement of fracture healing
23. Growth factor treatment of fractures
24. Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model
25. Gene therapy for bone formation: In vitro and in vivo osteogenic activity of an adenovirus expressing BMP7
26. Composites of bone morphogenetic protein (BMP) and type IV collagen, coral-derived coral hydroxyapatite, and tricalcium phosphate ceramics
27. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein-2
28. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion
29. Comparative utility of mineralized collagens as an osteoinductive material
30. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model
31. The use of bone morphogenetic protein in the treatment of nonunion in a canine model
32. Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: A review
33. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects: An experimental model of defect filling
34. An injectable endothermically setting calcium phosphate material bridges critical-sized defects in rabbits in combination with rhBMP-2
35. Options for tissue engineering to address challenges of the aging skeleton
36. Role of bone substitutes
37. Poly(a-hydroxy acids): Carriers for bone morphogenetic proteins
38. Calcium phosphate ceramics as hard tissue prosthetics
39. Encrypted morphogens of skeletogenesis: Biological errors and pharmacologic potentials
40. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant bone morphogenetic protein 2 (rhBMP-2)
41. Biodistribution and efficacy of rhBMP-2 in hyaluronan-based carriers
42. Injectable hyaluronic acid/tricalcium phosphate composites for the delivery of rhBMP-2
43. Potential applications and delivery strategies for bone morphogenetic proteins
44. Resorbable calcium phosphate bone substitute
45. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice
46. Healing of large segmental defects in rat femurs is aided by rhBMP-2 in PLGA matrix
47. Osteoprogenitor cells of mature human skeletal muscle tissue: An in vitro study
48. Delivering on the promise of bone morphogenetic proteins
49. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats
50. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents
51. Ectopic induction of cartilage and bone by water soluble proteins from bovine bone using a polyanhydride delivery vehicle
52. Osteoinductive bone graft substitutes
53. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: Important lessons learned regarding dose, carrier, and safety
54. Evaluation of carriers of bone morphogenetic protein for spinal fusion
55. Polylactic acid-polyethylene glycol block copolymer: A new biodegradable synthetic carrier for bone morphogenetic protein
56. Regulation of bone formation by bone morphogenetic proteins and other growth factors
57. Experimental anterior spine fusion using bovine bone morphogenetic protein: A study in rabbits
58. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone
59. Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2
60. The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells
61. Critical and noncritical size defect healing with osteogenic protein-1
62. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates
63. Potential role of fibroblast growth factor in the enhancement of fracture healing
64. Bone morphogenetic proteins: From basic science to clinical applications
65. Interplay between bone morphogenetic proteins and cognate binding proteins in bone and cartilage development: Noggin, chordin and DAN
66. Morphogenesis and tissue engineering of bone and cartilage: Inductive signals, stem cells, and biomimetic biomaterials
67. Development and characterization of a biodegradable polyphosphate
68. Bone morphogenetic protein-2: Biology and applications
69. Bone morphogenetic proteins: From basic studies to clinical approaches
70. Homology of bone inductive proteins from human, monkey, bovine, and rat extracellular matrix
71. Demineralized bone matrix, bone morphogenetic proteins, and animal models of spine fusion: An overview
72. Reconstruction of bone using calcium phosphate bone cements
73. Evaluation of recombinant human bone morphogenetic protein-2 as a bone-graft substitute in a canine segmental defect model
74. The influence of delivery vehicles and their properties on the repair of segmental defects and fractures with osteogenic factors
75. A Single Injection of rhBMP-2/calcium phosphate paste accelerates healing in a nonhuman primate osteotomy model
76. A single injection of rhBMP-2/calcium phosphate paste given one week after surgery accelerates osteotomy healing by 50% in a nonhuman primate fibula osteotomy model
77. Spinal fusion with recombinant human growth and differentiation factor-5 combined with a mineralized collagen matrix
78. Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein
79. Growth factors as therapeutic agents
80. Bone affinity of a bisphosphonateconjugated protein in vivo
81. Bone: Formation by autoinduction
82. Recombinant human bone morphogenetic protein induces bone formation
83. Study on the mechanism of bone formation of bioactive materials BMP/β-TCP restoring bone defects by using quantitative analysis methods
84. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds
85. Carrier systems for bone morphogenetic proteins
86. Sustained release emphasizing recombinant human bone morphogenetic protein-2
87. Novel regulators of bone formation: Molecular clones and activities